CD8A and neoplasm: The frequency of CD8+ T cells directed against the studied tumor antigens ranged from .01% to 1.6% (mean, .45%) of circulating CD8+ T cells, which is comparable to the frequency of cytomegalovirus-specific T cell responses detectable in cytomegalovirus-seropositive patients.